Is it prime time to consider a clinical trial of doxycycline for the management of COVID-19?

Affiliations

¹ Department of Internal Medicine, Faculty of Medicine, University of Ioannina, Ioannina, Greece.
² Respiratory Medicine Department, Faculty of Medicine, University of Ioannina, Ioannina, Greece ktkostikas@gmail.com.

Comment

Haralampos Milionis et al. Postgrad Med J. 2022 Mar.

. 2022 Mar;98(e2):e107.

doi: 10.1136/postgradmedj-2020-139358.

¹ Department of Internal Medicine, Faculty of Medicine, University of Ioannina, Ioannina, Greece.
² Respiratory Medicine Department, Faculty of Medicine, University of Ioannina, Ioannina, Greece ktkostikas@gmail.com.

No abstract available

Keywords: COVID-19; infection control.

Conflict of interest statement

Competing interests: None declared.

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
RECOVERY Collaborative Group; Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, Wiselka M, Ustianowski A, Elmahi E, Prudon B, Whitehouse T, Felton T, Williams J, Faccenda J, Underwood J, Baillie JK, Chappell LC, Faust SN, Jaki T, Jeffery K, Lim WS, Montgomery A, Rowan K, Tarning J, Watson JA, White NJ, Juszczak E, Haynes R, Landray MJ. RECOVERY Collaborative Group, et al. N Engl J Med. 2020 Nov 19;383(21):2030-2040. doi: 10.1056/NEJMoa2022926. Epub 2020 Oct 8. N Engl J Med. 2020. PMID: 33031652 Free PMC article. Clinical Trial.